Nuclear medicine copes with upheaval in pandemic
December 15, 2020 -- At one point this year, it looked like Europe's entire nuclear medicine sector would have to be put on hold, said Antonis Kalemis, PhD, president of Nuclear Medicine Europe. When COVID-19 began spreading rapidly, industry felt huge anxiety as the lockdown measures escalated, but it has pulled together and survived. Read More
What's new in noninvasive detection of skin cancer?
November 27, 2020 -- Researchers from Israel have developed and tested a fiberoptic evanescent wave spectroscopy system that can noninvasively identify and characterize skin cancers. They successfully identified cancerous lesions on patients' skin by touching the suspicious regions for 30 seconds with an optical fiber connected to a mid-infrared spectrometer. Read More
Total-body PET can prove a game changer
November 25, 2020 -- Higher image quality, lower patient and staff radiation exposure, simultaneous multiorgan imaging, and expanded range for optimal dose imaging are among the significant advantages that total-body PET can bring to the clinical setting, according to a leading hybrid imaging expert. Read More
German team unveils progress in pancreatic cancer staging
November 4, 2020 -- Investigators from Heidelberg University Hospital and the German Cancer Research Center are convinced that PET/CT using a fibroblast activation protein molecule inhibitor can open up new applications in staging and restaging of pancreatic ductal adenocarcinoma. Read More
Dutch use molecular scan to find new salivary glands
October 30, 2020 -- A group from the Netherlands Cancer Institute in Amsterdam has used PET/CT with a radiopharmaceutical based on a prostate-specific membrane antigen to discover a pair of salivary glands. Sparing these glands during radiation therapy may prevent treatment side effects and improve quality of life for head and neck cancer patients. Read More
PET/CT rules supreme in cases of neuroendocrine tumors
October 27, 2020 -- PET/CT has no rivals when it comes to the detection and surveillance of cardiac metastases in well-differentiated gastroenteropancreatic neuroendocrine tumors as well as guiding clinical management, according to research presented at the annual congress of the European Association of Nuclear Medicine. Read More
Dynamic PET edges closer to clinical prime time
October 27, 2020 -- Dynamic whole-body PET is evolving fast and showing considerable clinical promise, a leading French molecular imaging expert told the opening plenary session at the annual congress of the European Association of Nuclear Medicine. The technique is benefiting from artificial intelligence-based assistance to simplify the challenging and time-consuming tasks associated with the acquisition and analysis of data. Read More
PET moves ahead in detection of hypoxic tumors
October 21, 2020 -- Researchers have used PET to provide a new way to diagnose hypoxia in tumors. They demonstrated that signs of tumor hypoxia can be spotted among the gamma rays collected routinely during a PET scan, providing clinicians with extra information to guide treatment decisions. Read More
German group refines PET technique for prostate cancer
October 13, 2020 -- Researchers from Essen have used a PET-based optical imaging method known as Cerenkov luminescence imaging to highlight the presence of cancer cells after prostate cancer surgery. They published their results in the October edition of the Journal of Nuclear Medicine. Read More
Compton imaging opens up new diagnostic avenues
October 9, 2020 -- Compton imaging -- originally developed by astronomers for detecting gamma ray sources -- is now under investigation for clinical imaging. A high-performance Compton camera could prove invaluable for applications within nuclear medicine and molecular imaging, researchers have found. Read More